October 31, 2023 11:28 AM EDT
Manufacturing

As In­dia grows its bi­o­log­ics mar­ket, Ara­gen builds new $30M fa­cil­i­ty

Anna Brown

News Reporter

Ara­gen Life Sci­ences is launch­ing a new $30 mil­lion bi­o­log­ics man­u­fac­tur­ing site in Ban­ga­lore due to grow­ing de­mand, the In­dia-based drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

As­traZeneca takes $753M charge on aban­doned com­ple­ment drug from Alex­ion deal

Pfiz­er hires No­var­tis on­col­o­gy ex­ec to steer its can­cer am­bi­tions

Bris­tol My­ers launch­es fresh round of ma­jor cost cuts in bid to get ahead of patent cliff

Up­dat­ed: Lil­ly posts 45% sales jump, culls four pro­grams across obe­si­ty, Alzheimer's, heart fail­ure and eczema

J&J, In­tra-Cel­lu­lar quick­ly sealed $14B deal as three oth­ers passed on buy­ing the neu­ro drug­mak­er

As­traZeneca of­fers some de­tail on Chi­na probe, reaf­firms com­mit­ment to that mar­ket

A service from the Financial Times